✦ LIBER ✦
458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1
✍ Scribed by V. Detishin; W. Haazen; R. Hooijmaijers; M. Ruppert; K. Bol; H. Robison; L. Robarge; A. Agarwal; M. Deshpande; E. Olek
- Book ID
- 117379603
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 57 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.